Rituximab Superior to Mycophenolate Mofetil in Pemphigus Vulgaris Study Rituximab Superior to Mycophenolate Mofetil in Pemphigus Vulgaris Study

Significantly more patients on rituximab achieved a complete sustained remission in the interim analysis of the trial, which enrolled 135 patients with moderate to severe pemphigus.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news